About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 157 trials

CompletedVITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive…NCT00056225·Birmingham, Alabama and 37 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

TerminatedA Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study was to test whether two investigational drugs called CAD106 and CNP520, administered separately, could slow down the onset and progression of clinical…NCT02565511·Phoenix, Arizona and 128 others

CompletedProject COPE:Managing Dementia at HomeThis study tests the effectiveness of an in-home intervention to reduce upset and burden among family caregivers, and decrease nursing home placement.NCT00259454·Philadelphia, Pennsylvania

CompletedImaging Dementia-Evidence for Amyloid Scanning (IDEAS) StudyThe Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes.NCT02420756·Philadelphia, Pennsylvania and 1 other

CompletedImproving Everyday Task Performance Through Repeated Practice in Virtual Reality.There are very few effective interventions that promote functional independence in people with Alzheimer's disease (AD) and related dementias.NCT04315337·Philadelphia, Pennsylvania

CompletedMild Cognitive Impairment and Obstructive Sleep ApneaObstructive sleep apnea (OSA) has been linked to increased risk for Alzheimer's disease (AD), but little prospective evidence exists on the effects of OSA treatment in preclinical…NCT01482351·Abington, Pennsylvania and 2 others

CompletedEffects of ONO-2506PO in Patients With Alzheimer's DiseaseThe purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.NCT00083421·Birmingham, Alabama and 86 others

CompletedDISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac AmyloidosisThe purpose of this study is to characterize the frequency of TTR mutations in subjects suspected of having cardiac amyloidosisNCT02252653·Little Rock, Arkansas and 57 others

CompletedSafety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseThis is a global Phase III, randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD.NCT02547818·Gilbert, Arizona and 120 others

CompletedCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD).NCT00053599·Birmingham, Alabama and 43 others

CompletedEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyPhase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg administered orally twice a day compared to placebo in subjects with symptomatic Transthyretin Amyloid…NCT03860935·Los Angeles, California and 103 others

TerminatedOpen-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 ProtocolOpen-label treatment with MPC-7869 for participants in a previous randomized study.NCT00380276·Alabaster, Alabama and 89 others

CompletedA Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.NCT00566397·Phoenix, Arizona and 61 others

CompletedEvaluation of Reader Training ProcessesThis study is designed to evaluate the agreement between florbetapir F 18 scan interpretation in the clinic and by expert readers.NCT02051790·Philadelphia, Pennsylvania

CompletedTelehealth-enabled Integrated Palliative Care for People With DementiaIn prior work, this team developed a telehealth primary care model (TIPC), designed in close partnership with patients and clinicians to address a widespread increase in…NCT05524181·Philadelphia, Pennsylvania

CompletedResveratrol for Alzheimer's DiseaseResveratrol is derived from plants and is found in highest levels in red wine and the skin of red grapes.NCT01504854·Phoenix, Arizona and 25 others

RecruitingA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention, and make…NCT07589595·Chandler, Arizona and 71 others

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

CompletedInvestigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)This phase IIIb trial is a prospective, randomized, double-blind, placebo-controlled, 36-month study comparing the length of time of progression from mild cognitive impairment…NCT00000174·Peoria, Arizona and 14 others

Active not recruitingA Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in…NCT06653153·Birmingham, Alabama and 261 others

PreviousPage 7 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia